Skip to content
Back
Most recent
We’re listening to the macular disease community
The 2022 Supporter Survey results are in.
Eye Connect: What patients say
Specsavers and Macular Disease Foundation Australia have begun a strategic scoping partnership.
AREDS2 study confirms safety, efficacy of supplements
Researchers confirm the AREDS2 formulation is safe for use over a decade.
Faricimab one step closer
Faricimab has taken one step closer towards clinics in Australia.
Proposed MBS rebate cut rejected: Where to from here?
MDFA strives to address challenges for people receiving intravitreal injections.
Digital diabetic eye disease education
MDFA teams up with Healthily to deliver education via GPs.
“I don’t feel so alone anymore”
MDFA offers Peer to Peer phone calls as well as peer support groups, both face-to-face and online.
Forced to hang up her knitting needles
Sadly, eye injections came too late for Cheryl Chamberlain. But thousands of Australian patients will now be able to stick to this sight-saving treatment after both major political parties rejected a proposed Medicare rebate cut.
Relief after rebate cut rejected
Eye injections have saved the sight of thousands of Aussies since this vital treatment arrived here 15 years ago – including Magdalena from the Gold Coast.